Drug Delivery Market

Drug Delivery Market

Drug Delivery Market Forecasts to 2030 - Global Analysis By Type (Injectable Drug Delivery, Transdermal Drug Delivery, Oral Drug Delivery, Topical Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery, Ocular Drug Delivery and Other Types), Capacity (Single-vessel Systems, High-throughput Systems and Multi-vessel Systems), Distribution Channel, Application and By Geography.

4.1 (82 reviews)
4.1 (82 reviews)
Published: 2023 ID: SMRC24206

This report covers the impact of COVID-19 on this global market

Years Covered


Estimated Year Value (2023)

US $20.2 BN

Projected Year Value (2030)

US $35.5 BN

CAGR (2023 - 2030)


Regions Covered

North America, Europe, Asia Pacific, South America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa

Largest Market

Asia Pacific

Highest Growing Market

North America

According to Stratistics MRC, the Global Drug Delivery Market is accounted for $20.2 billion in 2023 and is expected to reach $35.5 billion by 2030 growing at a CAGR of 8.4% during the forecast period. Drug delivery refers to the process of administering pharmaceutical substances, such as drugs or therapeutic agents, to the human body in a controlled and targeted manner. It is essential for improving the therapeutic impact of pharmaceuticals, reducing side effects, and enhancing patient compliance. It plays a critical role in advancing medical treatments and the overall quality of patient care.

According to the American Heart Association, 101.5 million stroke cases worldwide in 2019. Ischemic stroke cases were 77.2 million, intracerebral hemorrhage cases were 20.7 million, and subarachnoid hemorrhage cases were 8.4 million.

Market Dynamics: 


Rise in precision medicine

Precision medicine tailors medical treatments, including drug therapies, to an individual's unique genetic, genomic, and physiological characteristics. This approach demands precise drug delivery systems that can target specific molecular pathways or cells with high accuracy. As a result, drug delivery technologies have evolved to accommodate the requirements of personalized medicine, enabling the administration of precise dosages at specific times and locations in the body. This ensures that the right treatment reaches the right patient, maximizing therapeutic effectiveness while minimizing side effects. 


High development costs

Researching and developing new drug delivery technologies, from formulation enhancements to advanced delivery systems, can be a financial burden. These costs encompass pre-clinical testing, clinical trials, regulatory approvals, and manufacturing processes. The complexity and innovation required for cutting-edge drug delivery systems further drive up expenses. Moreover, these high development costs can deter smaller companies from entering the market and may slow down the pace of innovation. It necessitates substantial financial investments and makes it challenging for companies to bring cost-effective solutions to market, ultimately affecting the accessibility and affordability of advanced drug delivery methods.


Growth of telemedicine and remote monitoring

The growth of telemedicine and remote patient monitoring presents a substantial opportunity for the drug delivery market. Telehealth's expanding popularity allows patients to access healthcare services from the comfort of their homes, reducing the need for in-person clinic visits. This shift towards remote care creates a demand for innovative drug delivery systems that enable patients to self-administer medications effectively and safely under remote medical supervision. Whether it's managing chronic conditions or delivering critical therapies, these remote drug delivery solutions can improve patient compliance, treatment outcomes, and overall healthcare efficiency. As telemedicine continues to gain momentum, the drug delivery market has the potential to develop and offer new, patient-centric technologies that align with the evolving landscape of healthcare delivery, ultimately enhancing the accessibility and effectiveness of drug treatments.


Cybersecurity risks

Cybersecurity risks represent a growing threat to the drug delivery market. As drug delivery systems become increasingly interconnected and reliant on digital technologies, they become susceptible to cyber attacks. Malicious actors could potentially compromise the security and functionality of these systems, endangering patient safety and the integrity of drug administration. Such attacks may lead to incorrect dosing, unauthorized access to patient data, or system failures. Ensuring the cybersecurity of these devices is imperative, as breaches can have severe consequences, eroding patient trust and industry reputation.

Covid-19 Impact

The outbreak of COVID-19 has disrupted workflows in the healthcare sector around the world due to factors such as reduced hospital admissions, disruptions in the supply chain, temporary halts in manufacturing, and others across the globe. The disease has forced a number of industries to temporarily shut their doors, including several sub-domains of health care. The global pharmaceutical drug delivery market was moderately impacted during the pandemic due to disruptions in the supply of pharmaceutical products. However, with the launch of COVID-19 vaccines and mass vaccination drives, there was a significant acceleration in manufacturers’ production of injectable drug delivery systems to meet global medical needs. The market in the post-pandemic period will grow significantly due to increased hospital visits and the launch of advanced drug delivery systems, among others. 

The Implantable Drug Delivery segment is expected to be the largest during the forecast period

The Implantable Drug Delivery segment is estimated to hold the largest share. Implantable drug delivery is a specialized segment of the drug delivery market that involves the use of medical devices designed to deliver pharmaceutical agents directly into the body for controlled and sustained release. These devices, often implanted under the skin or within specific bodily tissues, can administer drugs over extended periods, reducing the need for frequent dosing. Implantable drug delivery systems are used in various medical applications, including the treatment of chronic conditions such as diabetes and pain management, offering patients convenience and improved therapeutic outcomes while minimizing potential side effects. This segment represents an innovative approach to enhancing drug efficacy and patient compliance. 

The Cardiovascular Diseases segment is expected to have the highest CAGR during the forecast period

The Cardiovascular Diseases segment is anticipated to have lucrative growth during the forecast period. Cardiovascular diseases (CVD) represent a significant and multifaceted segment within the drug delivery market. This sector is dedicated to developing innovative drug delivery systems and therapies aimed at preventing, managing, and treating conditions such as hypertension, coronary artery disease, heart failure, and stroke. Drug delivery technologies for CVD encompass a wide range of solutions, including controlled-release formulations, stents coated with medications to prevent artery blockage, and novel delivery methods for anticoagulants and antiplatelet agents. These advancements improve the efficacy of medications, enhance patient compliance, and reduce the risk of adverse cardiovascular events. Moreover, with CVD being a leading cause of mortality worldwide, the cardiovascular drug delivery market plays a pivotal role in mitigating this public health crisis by providing solutions that contribute to better outcomes and overall cardiovascular health.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period. The rising incidence of cancer and growing public knowledge of cancer treatments are the main causes of this region's market expansion. With a vast population, the Asia-Pacific region has experienced an increase in cancer prevalence in recent years as a result of changing lifestyles, environmental factors, and aging populations. As a result, there are an increasing number of patients receiving treatment, which raises the need for the distribution of pharmaceutical drugs. Moreover, due to the increase in disposable income as well as the lucrative potential for major participants in the market, Asia-Pacific is expected to develop at the highest rate during the forecast period. Furthermore, manufacturers in India are increasing their production capacities to meet the rising demand for syringes, thereby fostering overall market growth across the region. 

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period. This is attributed to several factors, including the increased occurrence of chronic illnesses including diabetes, cancer, and respiratory allergies; increased patient adherence to novel drug delivery technology; and the concentration of notable individuals in this area. The market is expanding due to the presence of many significant players, including Novartis AG, Pfizer Inc., F. Hoffmann La-Roche Ltd., and Merck and Co., Inc., in the area. Moreover, the need for pharmaceutical drug delivery solutions in North America is growing rapidly due to the biopharmaceutical industry's development of numerous novel medications that can cure a range of non-communicable disorders.

Key players in the market

Some of the key players in the Drug Delivery Market include Abbott, Bayer, AstraZeneca, Sanofi, GlaxoSmithKline, La Roche, Johnson & Johnson, Novartis AG, Merck, Pfizer, Antares Pharma, GSK, Accord Healthcare, Becton Dickinson and Co, Boston Scientific Corp, Baxter International Inc, Kindeva Drug Delivery LP, Gerresheimer AG, Sever Pharma Solutions and Boehringer Ingelheim International.

Key Developments:

In December 2022, Johnson & Johnson announced the launch of its ACUITY™ MRI SureScan™ pacemaker. This pacemaker is the first and only MRI-conditional pacemaker that is also compatible with Johnson & Johnson's ACUITY™ MRI SureScan™ defibrillator.

In November 2022, Sorin Group announced the launch of its Evia™ leadless pacemaker. This pacemaker is a small, wireless device that is implanted directly into the heart without the need for leads.

In October 2022, Arena Pharmaceuticals announced the approval of its drug, ravulizumab, for the treatment of paroxysmal nocturnal hemoglobinuria (PNH). Ravulizumab is a long-acting, subcutaneously administered C5 complement inhibitor that provides sustained protection from hemolysis in patients with PNH.

In September 2022, Alnylam Pharmaceuticals announced the approval of its drug, vutrisiran, for the treatment of hereditary transthyretin amyloidosis (ATTR amyloidosis). Vutrisiran is a subcutaneously administered RNA interference (RNAi) therapy that targets the production of TTR protein.

In August 2022, Sanofi announced the approval of its drug, Dupixent, for the treatment of atopic dermatitis in adults and children aged 6 years and older. Dupixent is a human monoclonal antibody that targets the IL-4 and IL-13 cytokines.

Types Covered:
• Injectable Drug Delivery 
• Transdermal Drug Delivery 
• Oral Drug Delivery 
• Topical Drug Delivery 
• Transmucosal Drug Delivery 
• Implantable Drug Delivery 
• Ocular Drug Delivery 
• Other Types 

Device Types Covered:
• Advanced
• Conventional

Distribution Channels Covered:
• Retail Pharmacies
• Hospital Pharmacies 
• Online Pharmacies 
• Other Distribution Channels 

Applications Covered:
• Oncology
• Cardiovascular Diseases
• Diabetes
• Central Nervous System Disorders
• Respiratory Diseases
• Other Applications

End Users Covered:
• Home Care Settings 
• Hospitals and Clinics 
• Ambulatory Surgical Centers 
• Other End Users 

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings: 
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary       
2 Preface        
 2.1 Abstract       
 2.2 Stake Holders      
 2.3 Research Scope      
 2.4 Research Methodology     
  2.4.1 Data Mining     
  2.4.2 Data Analysis     
  2.4.3 Data Validation     
  2.4.4 Research Approach     
 2.5 Research Sources      
  2.5.1 Primary Research Sources    
  2.5.2 Secondary Research Sources    
  2.5.3 Assumptions     
3 Market Trend Analysis      
 3.1 Introduction      
 3.2 Drivers       
 3.3 Restraints      
 3.4 Opportunities      
 3.5 Threats       
 3.6 Application Analysis     
 3.7 End User Analysis      
 3.8 Emerging Markets      
 3.9 Impact of Covid-19      
4 Porters Five Force Analysis      
 4.1 Bargaining power of suppliers     
 4.2 Bargaining power of buyers     
 4.3 Threat of substitutes     
 4.4 Threat of new entrants     
 4.5 Competitive rivalry      
5 Global Drug Delivery Market, By Type     
 5.1 Introduction      
 5.3 Injectable Drug Delivery     
 5.4 Transdermal Drug Delivery     
 5.5 Oral Drug Delivery      
 5.6 Topical Drug Delivery     
 5.7 Transmucosal Drug Delivery     
 5.8 Implantable Drug Delivery     
 5.9 Ocular Drug Delivery     
 5.1 Other Types      
6 Global Drug Delivery Market, By Device Type    
 6.1 Introduction      
 6.2 Advanced      
 6.3 Conventional      
7 Global Drug Delivery Market, By Distribution Channel   
 7.1 Introduction      
 7.2 Retail Pharmacies      
 7.3 Hospital Pharmacies     
 7.4 Online Pharmacies      
 7.5 Other Distribution Channels     
8 Global Drug Delivery Market, By Application    
 8.1 Introduction      
 8.2 Oncology       
 8.3 Cardiovascular Diseases     
 8.4 Diabetes       
 8.5 Central Nervous System Disorders    
 8.6 Respiratory Diseases     
 8.7 Other Applications      
9 Global Drug Delivery Market, By End User    
 9.1 Introduction      
 9.2 Home Care Settings      
 9.3 Hospitals and Clinics     
 9.4 Ambulatory Surgical Centers     
 9.5 Other End Users      
10 Global Drug Delivery Market, By Geography    
 10.1 Introduction      
 10.2 North America      
  10.2.1 US      
  10.2.2 Canada      
  10.2.3 Mexico      
 10.3 Europe       
  10.3.1 Germany      
  10.3.2 UK      
  10.3.3 Italy      
  10.3.4 France      
  10.3.5 Spain      
  10.3.6 Rest of Europe     
 10.4 Asia Pacific      
  10.4.1 Japan      
  10.4.2 China      
  10.4.3 India      
  10.4.4 Australia      
  10.4.5 New Zealand     
  10.4.6 South Korea     
  10.4.7 Rest of Asia Pacific     
 10.5 South America      
  10.5.1 Argentina     
  10.5.2 Brazil      
  10.5.3 Chile      
  10.5.4 Rest of South America    
 10.6 Middle East & Africa     
  10.6.1 Saudi Arabia     
  10.6.2 UAE      
  10.6.3 Qatar      
  10.6.4 South Africa     
  10.6.5 Rest of Middle East & Africa    
11 Key Developments       
 11.1 Agreements, Partnerships, Collaborations and Joint Ventures  
 11.2 Acquisitions & Mergers     
 11.3 New Product Launch     
 11.4 Expansions      
 11.5 Other Key Strategies     
12 Company Profiling       
 12.1 Abbott       
 12.2 Bayer       
 12.3 AstraZeneca      
 12.4 Sanofi       
 12.5 GlaxoSmithKline      
 12.6 La Roche       
 12.7 Johnson & Johnson      
 12.8 Novartis AG      
 12.9 Merck       
 12.10 Pfizer       
 12.11 Antares Pharma      
 12.12 GSK       
 12.13 Accord Healthcare      
 12.14 Becton Dickinson and Co     
 12.15 Boston Scientific Corp     
 12.16 Baxter International Inc     
 12.17 Kindeva Drug Delivery LP     
 12.18 Gerresheimer AG      
 12.19 Sever Pharma Solutions     
 12.20 Boehringer Ingelheim International    
List of Tables        
1 Global Drug Delivery Market Outlook, By Region (2021-2030) ($MN)  
2 Global Drug Delivery Market Outlook, By Type (2021-2030) ($MN)  
3 Global Drug Delivery Market Outlook, By Injectable Drug Delivery (2021-2030) ($MN)
4 Global Drug Delivery Market Outlook, By Transdermal Drug Delivery (2021-2030) ($MN)
5 Global Drug Delivery Market Outlook, By Oral Drug Delivery (2021-2030) ($MN) 
6 Global Drug Delivery Market Outlook, By Topical Drug Delivery (2021-2030) ($MN) 
7 Global Drug Delivery Market Outlook, By Transmucosal Drug Delivery (2021-2030) ($MN)
8 Global Drug Delivery Market Outlook, By Implantable Drug Delivery (2021-2030) ($MN)
9 Global Drug Delivery Market Outlook, By Ocular Drug Delivery (2021-2030) ($MN) 
10 Global Drug Delivery Market Outlook, By Other Types (2021-2030) ($MN)  
11 Global Drug Delivery Market Outlook, By Device Type (2021-2030) ($MN)  
12 Global Drug Delivery Market Outlook, By Advanced (2021-2030) ($MN)  
13 Global Drug Delivery Market Outlook, By Conventional (2021-2030) ($MN) 
14 Global Drug Delivery Market Outlook, By Distribution Channel (2021-2030) ($MN) 
15 Global Drug Delivery Market Outlook, By Retail Pharmacies (2021-2030) ($MN) 
16 Global Drug Delivery Market Outlook, By Hospital Pharmacies (2021-2030) ($MN) 
17 Global Drug Delivery Market Outlook, By Online Pharmacies (2021-2030) ($MN) 
18 Global Drug Delivery Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
19 Global Drug Delivery Market Outlook, By Application (2021-2030) ($MN)  
20 Global Drug Delivery Market Outlook, By Oncology (2021-2030) ($MN)  
21 Global Drug Delivery Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
22 Global Drug Delivery Market Outlook, By Diabetes (2021-2030) ($MN)  
23 Global Drug Delivery Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN)
24 Global Drug Delivery Market Outlook, By Respiratory Diseases (2021-2030) ($MN) 
25 Global Drug Delivery Market Outlook, By Other Applications (2021-2030) ($MN) 
26 Global Drug Delivery Market Outlook, By End User (2021-2030) ($MN)  
27 Global Drug Delivery Market Outlook, By Home Care Settings (2021-2030) ($MN) 
28 Global Drug Delivery Market Outlook, By Hospitals and Clinics (2021-2030) ($MN) 
29 Global Drug Delivery Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
30 Global Drug Delivery Market Outlook, By Other End Users (2021-2030) ($MN) 
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

List of Figures


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.

Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.

For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.


Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.